[go: up one dir, main page]

BG100747A - INDOLE DERIVATIVES AS 5-HT1 agonists - Google Patents

INDOLE DERIVATIVES AS 5-HT1 agonists

Info

Publication number
BG100747A
BG100747A BG100747A BG10074796A BG100747A BG 100747 A BG100747 A BG 100747A BG 100747 A BG100747 A BG 100747A BG 10074796 A BG10074796 A BG 10074796A BG 100747 A BG100747 A BG 100747A
Authority
BG
Bulgaria
Prior art keywords
agonists
group
indole derivatives
optionally substituted
alkyl
Prior art date
Application number
BG100747A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Glen
Christopher Foster
David Selwood
Graeme Martin
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of BG100747A publication Critical patent/BG100747A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG100747A 1994-01-26 1996-07-25 INDOLE DERIVATIVES AS 5-HT1 agonists BG100747A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401436A GB9401436D0 (en) 1994-01-26 1994-01-26 Therapeutic heterocyclic compounds
PCT/GB1995/000142 WO1995020588A1 (en) 1994-01-26 1995-01-25 Indole derivatives as 5-ht1 agonists

Publications (1)

Publication Number Publication Date
BG100747A true BG100747A (en) 1997-03-31

Family

ID=10749321

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100747A BG100747A (en) 1994-01-26 1996-07-25 INDOLE DERIVATIVES AS 5-HT1 agonists

Country Status (26)

Country Link
US (3) US5744466A (xx)
EP (1) EP0741725A1 (xx)
JP (1) JPH09512248A (xx)
CN (1) CN1143960A (xx)
AP (1) AP632A (xx)
AU (2) AU689195B2 (xx)
BG (1) BG100747A (xx)
BR (1) BR9506581A (xx)
CA (1) CA2181475A1 (xx)
CZ (1) CZ216996A3 (xx)
EE (1) EE9600095A (xx)
FI (1) FI962969A7 (xx)
GB (1) GB9401436D0 (xx)
HU (1) HUT76288A (xx)
IL (1) IL112443A (xx)
MX (1) MX9602979A (xx)
NO (1) NO963117L (xx)
NZ (1) NZ278644A (xx)
OA (1) OA10307A (xx)
PL (1) PL315666A1 (xx)
SG (1) SG44926A1 (xx)
SK (1) SK96796A3 (xx)
TW (1) TW377344B (xx)
WO (1) WO1995020588A1 (xx)
YU (1) YU4795A (xx)
ZA (1) ZA95601B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376463B1 (en) * 1992-04-07 2002-04-23 Emory University Modified factor VIII
GB9515060D0 (en) * 1995-07-22 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
GB9515305D0 (en) * 1995-07-26 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
GB9516143D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US6909005B1 (en) 1995-08-07 2005-06-21 Astrazeneca Uk Limited One post synthesis of 2-oxazolidinone derivatives
AU2104097A (en) * 1996-03-13 1997-10-01 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
US5654431A (en) * 1996-05-30 1997-08-05 Meng; Qingchang 5-alkoxy tryptamine derivatives
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
CA2339662A1 (en) * 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, their production and use
MXPA02004555A (es) * 1999-11-08 2004-09-10 Wyeth Corp Azetidinas de [(indol-??3-il)cicloalquil]-3-substituidas para el tratamiento de padecimientos del sistema nervioso central.
US6245799B1 (en) 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
AU2001262113A1 (en) * 2000-03-23 2001-10-03 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
US6462234B2 (en) * 2000-09-18 2002-10-08 Pharmacia & Upjohn Company Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide
CA2433100A1 (en) 2000-12-27 2002-07-04 Helmut Haning Indole derivatives as ligands of thyroid receptors
US7553964B2 (en) 2005-06-03 2009-06-30 Abbott Laboratories Cyclobutyl amine derivatives
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
MX2008016343A (es) 2006-06-23 2009-01-19 Abbott Lab Derivados ciclopropil amina como moduladores del receptro de histamina h3.
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US9580431B2 (en) 2013-03-13 2017-02-28 VIIV Healthcare UK (No.5) Limited Inhibitors of human immunodeficiency virus replication
CN112209938B (zh) * 2019-07-11 2021-06-11 苏州亚盛药业有限公司 2-吲哚啉螺环酮类化合物的制备方法及其中间体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
IL92096A0 (en) * 1988-10-25 1990-07-12 Abbott Lab Carboxylic nucleoside analogs
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds
JPH07509452A (ja) * 1992-07-24 1995-10-19 メルク シヤープ エンド ドーム リミテツド イミダゾール,トリアゾール及びテトラゾール誘導体

Also Published As

Publication number Publication date
JPH09512248A (ja) 1997-12-09
YU4795A (sh) 1998-12-23
HUT76288A (en) 1997-07-28
ZA95601B (en) 1996-07-25
US5744466A (en) 1998-04-28
AP9600834A0 (en) 1996-07-31
HU9602035D0 (en) 1996-09-30
WO1995020588A1 (en) 1995-08-03
IL112443A (en) 1998-12-27
CZ216996A3 (en) 1997-06-11
FI962969A0 (fi) 1996-07-25
AU1462095A (en) 1995-08-15
FI962969L (fi) 1996-07-25
NO963117D0 (no) 1996-07-25
OA10307A (en) 1997-10-07
MX9602979A (es) 1998-01-31
CA2181475A1 (en) 1995-08-03
EE9600095A (et) 1996-12-16
SG44926A1 (en) 1997-12-19
CN1143960A (zh) 1997-02-26
AU6348998A (en) 1998-06-18
NZ278644A (en) 1998-02-26
PL315666A1 (en) 1996-11-25
BR9506581A (pt) 1997-09-23
US5922748A (en) 1999-07-13
AP632A (en) 1998-03-30
EP0741725A1 (en) 1996-11-13
GB9401436D0 (en) 1994-03-23
SK96796A3 (en) 1997-06-04
NO963117L (no) 1996-09-23
AU689195B2 (en) 1998-03-26
US6103752A (en) 2000-08-15
IL112443A0 (en) 1995-03-30
TW377344B (en) 1999-12-21
FI962969A7 (fi) 1996-07-25

Similar Documents

Publication Publication Date Title
BG100747A (en) INDOLE DERIVATIVES AS 5-HT1 agonists
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
DE69620443D1 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
EA200200873A1 (ru) Новые пиперазиновые производные
EA200600348A1 (ru) Новые соединения
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
RU94027576A (ru) Производные 1-бензолсульфонил-1,3-дигидро-индол-2-она, способ их получения и содержащие их фармацевтические композиции
RU95116357A (ru) Производные пирролидина и тиазолидина, способы их получения, способ разделения энантиомеров и фармацевтическая композиция на основе производных пирролидина и тиазолидина
MX9504349A (es) Derivados de aroilpiperidina.
MX9804107A (es) Derivados de quinolina.
DK0594702T3 (da) Substituerede indoler som midler mod AIDS
EA199700098A1 (ru) Производные индола, пригодные для лечения остеопороза
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DE10199016I2 (de) Indol derivate zur Behandlung von Migraene
SE8505715D0 (sv) Indolderivat
EA200000023A1 (ru) Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола
CO4700452A1 (es) Derivados de indol
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
NO173869C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,7-kondenserte 1h-indol-2-carboxylsre-n-(1,4-benzodiazepin-3-yl)-amider
EA200100523A1 (ru) 3-[бенз(окс/ти)азол-7-ил]-1h-пиримидин-2,4-дионы
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
ATE237611T1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
DE69201184D1 (de) 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten.
FI970449A0 (fi) N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider